You have 9 free searches left this month | for more free features.

Presbyopia,Healthy Subject,Subjects with Presbyopia

Showing 1 - 25 of >10,000

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Eye Diseases, Presbyopia, Refractive Errors Trial in Newport Beach (Aceclidine + Brimonidine, Aceclidine)

Recruiting
  • Eye Diseases
  • +5 more
  • Newport Beach, California
    Site #101
Jul 7, 2023

Presbyopia Trial (Phentolamine Opthalmic Solution 0.75%, Placebo, Low dose pilocarpine)

Not yet recruiting
  • Presbyopia
  • Phentolamine Opthalmic Solution 0.75%
  • +3 more
  • (no location specified)
Dec 2, 2022

Presbyopia Trial in Glendale, Memphis (0.1% STN1013600 ophthalmic solution, 0.3% STN1013600 ophthalmic solution, Placebo)

Recruiting
  • Presbyopia
  • 0.1% STN1013600 ophthalmic solution
  • +2 more
  • Glendale, California
  • +1 more
Jan 12, 2023

Presbyopia, Near Vision, Miosis Trial in Chandler, Glendale (Aceclidine+Brimonidine combination ophthalmic solution, Placebo,

Recruiting
  • Presbyopia
  • +3 more
  • Aceclidine+Brimonidine combination ophthalmic solution
  • +2 more
  • Chandler, Arizona
  • +1 more
Mar 2, 2023

Presbyopia Trial in Worldwide (UNR844, Placebo)

Terminated
  • Presbyopia
  • Laguna Hills, California
  • +19 more
Jan 23, 2023

Presbyopia Trial in Memphis (BRIMOCHOL™ PF, Carbachol PF, Brimonidine tartrate)

Recruiting
  • Presbyopia
  • BRIMOCHOL™ PF
  • +2 more
  • Memphis, Tennessee
    Total Eye Care, PA
Apr 25, 2022

Refractive Error Trial in United States (iDesign Refractive Studio with STAR S4 IR® Excimer laser System)

Recruiting
  • Refractive Error
  • iDesign Refractive Studio with STAR S4 IR® Excimer laser System
  • Los Angeles, California
  • +9 more
Jan 23, 2023

Presbyopia Trial in United States (Phentolamine Ophthalmic Solution 0.75%, Pilocarpine, Placebo)

Completed
  • Presbyopia
  • Phentolamine Ophthalmic Solution 0.75%
  • +2 more
  • Laguna Hills, California
  • +16 more
Jun 20, 2022

Presbyopia Trial in United States (AGN-241622, AGN-190584, Vehicle)

Recruiting
  • Presbyopia
  • Inglewood, California
  • +10 more
Dec 8, 2021

Presbyopia Trial (AGN-190584)

Not yet recruiting
  • Presbyopia
  • (no location specified)
Nov 21, 2022

Presbyopia Trial in Glendale, Newport Beach, Memphis (BRIMOCHOL™, BRIMOCHOL™ F, Carbachol)

Completed
  • Presbyopia
  • Glendale, California
  • +2 more
Nov 5, 2021

Presbyopia Trial in United States (UNR844-Cl, Placebo)

Completed
  • Presbyopia
  • Mission Hills, California
  • +13 more
Apr 18, 2022

Presbyopia Trial in Crystal River (BRIMOCHOL™ PF, Carbachol PF, Vehicle)

Recruiting
  • Presbyopia
  • BRIMOCHOL™ PF
  • +2 more
  • Chandler, Arizona
  • +42 more
Sep 30, 2022

Presbyopia Trial in United States (AGN-190584, Vehicle)

Withdrawn
  • Presbyopia
  • Dothan, Alabama
  • +31 more
Jun 24, 2022

Presbyopia Trial in United States (AGN-190584, Vehicle)

Completed
  • Presbyopia
  • Bakersfield, California
  • +22 more
Feb 14, 2022

Presbyopia Trial in United States (CSF-1, Vehicle)

Completed
  • Presbyopia
  • Newport Beach, California
  • +12 more
Dec 13, 2022

Healthy Trial in Hangzhou (LPM3480392, Placebo)

Completed
  • Healthy
  • Hangzhou, Zhejiang, China
    The second affiliated hosipital zhejiang university school of me
May 15, 2023

Healthy Subject Trial in Chengdu (GS3-007 oral liquid)

Not yet recruiting
  • Healthy Subject
  • GS3-007 oral liquid
  • Chengdu, Sichuan, China
    Chengdu Xinhua Hospital Affiliated to North Sichuan Medical Coll
Jun 16, 2023

Healthy Subject Trial in Seoul (Neomazine Tab. 100mg, Myungin Chlorpromazine HCl Tab. 100mg)

Completed
  • Healthy Subject
  • Neomazine Tab. 100mg
  • Myungin Chlorpromazine HCl Tab. 100mg
  • Seoul, Korea, Republic of
    Whan In Pharm.
Nov 23, 2023

Healthy Trial in Qingdao (Test Empagliflozin And Linagliptin Tablets, Reference Empagliflozin And Linagliptin tablets)

Completed
  • Healthy
  • Test Empagliflozin And Linagliptin Tablets
  • Reference Empagliflozin And Linagliptin tablets
  • Qingdao, Shandong, China
    The Affiliated Hospital of Qingdao University Phase I Clinical R
Jul 14, 2023

Healthy Subject Trial in Seongnam, Daejeon (CT-P41, US-licensed Prolia)

Completed
  • Healthy Subject
  • CT-P41
  • US-licensed Prolia
  • Seongnam, Bundang-gu, Korea, Republic of
  • +1 more
Sep 7, 2023

Healthy Subject Trial in Xingtai (STSA-1002 Injection, STSA-1005 Injection)

Recruiting
  • Healthy Subject
  • STSA-1002 Injection
  • STSA-1005 Injection
  • Xingtai, Hebei, China
    The Second Affiliated Hospital Of Xingtai Medical College
Nov 22, 2022

Healthy Subject Trial in Beijing (Orelabrutinib and (orelabrutinib tablet simulator), Orelabrutinib, Placebo (orelabrutinib

Active, not recruiting
  • Healthy Subject
  • Orelabrutinib and placebo (orelabrutinib tablet simulator)
  • +3 more
  • Beijing, China
    Beijing GoBroad Boren Hospital
Dec 19, 2022

Presbyopia Trial in Mexico City (Compound Pilocarpine, Brimonidine, Oxymetazoline, Hyaluronic acid, Bromfenac, Pilocarpine

Recruiting
  • Presbyopia
  • Compound Pilocarpine, Brimonidine, Oxymetazoline, Hyaluronic acid, Bromfenac
  • +2 more
  • Mexico City, Mexico
    Optall Vision
Aug 14, 2021

Healthy Volunteer Trial in Cypress (MT1013)

Completed
  • Healthy Volunteer
  • Cypress, California
    WCCT Global, Inc.
Jul 28, 2022